What's New
Front Page
New Study Highlights Tradeoff Between Grammar and Word Choice in People with PPA
A study published in the medical journal Proceedings of the National Academy of Sciences revealed some ways…
Passage Bio Issues First Dose in FTD Gene Therapy Trial
Passage Bio, a company that specializes in developing genetic therapies, administered the first dose in a clinical…
Tony-Winning Broadway Playwright Diagnosed with lvPPA
Christopher Durang, a playwright renowned for his absurdist and comedic writing style, has quietly backed away from…
Newspaper Editor Writes About Wife’s PPA Journey
Earlier this year, Blake Ovard, an AFTD volunteer and editor for the Hobbs News-Sun newspaper in New…
Ten Years of NAPA: Ensuring That Families Facing FTD Have a Seat at the Table
The National Plan to Address Alzheimer’s Disease marked its 10th anniversary in 2022, and AFTD has consistently…
AFTD Webinar: Maximizing Communication, Maintaining Connection — Person-Centered Care for PPA
Primary progressive aphasia (PPA) is a clinical neurodegenerative dementia syndrome, which can be caused by Alzheimer’s disease…
AFTD News: Summer 2022, Vol. 19, Issue 2
In this issue: First Annual Holloway Summit Focuses on Digital Assessment Tools for FTD; 1,200+ Join AFTD’s…
AFTD’s HelpLine: A Vital Resource for Families Facing FTD
Since 2005, AFTD’s HelpLine has been an essential source of support and information for persons living with…
Support for the FTD Journey
“This disease hits people when they are in the prime of their life. It can be financially…
Spotlight on… Jary Larsen, PhD, AFTD Board of Directors
Jary Larsen’s late brother Peter learned to play the clarinet and saxophone as an adult. A life-long…
English 
Spanish (Mexico) 
French 
German 
Swedish 
Portuguese 
Italian 
Dutch 
Danish 
Polish 
Spanish (Spain)